Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer

New England Journal of Medicine

Volumn 337, Issue 17, 1997, Pages 1188-1194

  Izbicki, Jakob Robert ^a   Hosch, Stefan Benedikt ^a   Pichlmeier, Uwe ^b   Rehders, Alexander ^a   Busch, Christoph ^a   Niendorf, Axel ^b   Passlick, Bernward ^a   Broelsch, Christoph Erich ^a   Pantel, Klaus ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0030661825     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199710233371702     Document Type: Article

References (34)

1. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216:583-90.
2. Siewert JR, Bartels H, Bollschweiler E, et al. Plattenepithelcarcinom des Oesophagus: Behandlungskonzept der Chirurgischen Klinik der Technischen Universität Munchen. Chirurg 1992;63:693-700.
3. Watanabe H. Plattenepithelcarcinom des Oesophagus. Chirurg 1992; 63:689-92.
4. Earlam R. Epidemiology of esophageal cancer from the European point of view. In: Siewert JR, Hölscher AH, eds. Diseases of the esophagus. Berlin, Germany: Springer-Verlag, 1988:11-7.
5. Goldminc M, Maddern G, Le Prise E, Meunier B, Campion JP, Launois B. Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 1993;80:367-70.
6. Hennessy TPJ. Lymph node dissection. World J Surg 1994;18:367-72.
7. Morita M, Kuwano H, Ohno S, Furusawa M, Sugimachi K. Characteristics and sequence of the recurrent patterns after curative esophagectomy for squamous cell carcinoma. Surgery 1994;116:1-7.
8. Abe S, Tachibana M, Shiraishi M, Nakamura T. Lymph node metastasis in resectable esophageal cancer. J Thorac Cardiovasc Surg 1990;100:287-91.
9. Byrne J, Waldron R, McAvinchey D, Dervan P. The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases. Eur J Surg Oncol 1987;13:409-11.
10. Passlick B, Izbicki JR, Kubuschok B, et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol 1994;12:1827-32.
11. Raymond WA, Leong AL. Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer. Pathology 1989;21: 11-5.
12. Latza U, Niedobitek G, Schwarting R, Nekarda N, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990;43:213-9.
13. Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer 1986;54:631-6.
14. Chen ZL, Perez S, Holmes CE, et al. Frequency and distribution of occult micrometastasis in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 1993;85:493-8.
15. de Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992;66:523-7.
16. Hermanek P, Sobin LH. TNM classification of malignant tumours. 4th ed. New York: Springer, 1992.
17. Martini N, Flehinger BJ, Zaman MB, Beattie EJ Jr. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983;198:386-97.
18. Casson AG, Rusch VW, Ginsberg RJ, Zankowicz N, Finley RJ. Lymph node mapping of esophageal cancer. Ann Thorac Surg 1994;58:1569-70.
19. Momburg F, Moldenhauer G, Hammerling GJ, Moller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 1987;47:2883-91.
20. Pantel K, Schlimok G, Angstwurm M, et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994;3:165-73.
21. Kasper M, Stosiek P, Typlt H, Karsten U. Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues. Eur J Cancer Clin Oncol 1987;23:137-47.
22. Vogel SB, Mendenhall WM, Sombeck MD, Marsh R, Woodward ER. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 1995;221:685-93.
23. Lerut TE, de Leyn P, Coosemans W, Van Raemdonck D, Cuypers P, Van Cleynenbreughel B. Advanced esophageal carcinoma. World J Surg 1994;18:379-87.
24. Jauch KW, Bacha EA, Denecke H, Anthuber M, Schildberg FW. Esophageal carcinoma: prognostic features and comparison between blunt transhiatal dissection and transthoracic resection. Eur J Surg Oncol 1992; 18:553-62.
25. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
26. Schemper M, Smith TL. A note on quantifying follow-up studies of failure time. Control Clin Trials 1996;17:343-6.
27. Millikan KW, Silverstein J, Hart V, et al. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia. Arch Surg 1995;130: 617-24.
28. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer 1996;78:1820-8.
29. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265: 1287-9.
30. Chen MYM, Ott DJ, Gelfand DW. More evidence for the increasing prevalence of adenocarcinoma of the esophagus over an 18-year period. J Clin Gastroenterol 1995;21:254-5.
31. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
32. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990;335:1565-8.
33. O'Sullivan GC, Collins JK, O'Brien F, et al. Micrometastases in bone marrow of patients undergoing "curative" surgery for gastrointestinal cancer. Gastroenterology 1995;109:1535-40.
34. Thorban S, Roder JD, Nekarda H, Funk A, Siewert JR, Pantel K. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma. J Natl Cancer Inst 1996;88: 1222-7.